Characterization of cells prepared by dendritic cell-tumor cell fusion

Cancer Immunity

Volumn 5, Issue , 2002, Pages 1-11

  Gottfried, Eva ^a   Krieg, René ^a   Eichelberg, Christian ^a   Andreesen, Reinhard ^a   Mackensen, Andreas ^a   Krause, Stefan W ^a,b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Cell fusion; Cultured tumor cells; Dendritic cells; Hybrid cells

Indexed keywords

INTERLEUKIN 2; MACROGOL; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL FUSION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ELECTROFUSION (CELL); FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYBRID CELL; IN VITRO STUDY; PHAGOCYTOSIS; T LYMPHOCYTE ACTIVATION; TUMOR CELL;

EID: 3242760571     PISSN: 14249634     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252. (PMID: 9521319)
2. Kurokawa T, Oelke M, Mackensen A. Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells. Int J Cancer 2001; 91: 749-756. (PMID: 11275975)
3. Thurner B, Haendle I, Roder C, Dieckmann D, Keikavoussi P, Jonuleit H, Bender A, Maczek C, Schreiner D, von den Driesch P, Brocker EB, Steinman RM, Enk A, Kampgen E, Schuler G. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 1999; 190: 1669-1678. (PMID: 10587357)
4. Mackensen A, Herbst B, Chen JL, Kohler G, Noppen C, Herr W, Spagnoli GC, Cerundolo V, Lindemann A. Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells. Int J Cancer 2000; 86: 385-392. (PMID: 10760827)
5. Paglia P, Chiodoni C, Rodolfo M, Colombo MP. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 1996; 183: 317-322. (PMID: 8551239)
6. Reeves ME, Royal RE, Lam JS, Rosenberg SA, Hwu P. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res 1996; 56: 5672-5677. (PMID: 8971174)
7. Nair SK, Snyder D, Rouse BT, Gilboa E. Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts. Int J Cancer 1997; 70: 706-715. (PMID: 9096653)
8. Fields RC, Shimizu K, Mule JJ. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc Natl Acad Sci U S A 1998; 95: 9482-9487. (PMID: 9689106)
9. Gong J, Chen D, Kashiwaba M, Kufe D. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat Med 1997; 3: 558-561. (PMID: 9142127)
10. Soruri A, Fayyazi A, Neumann C, Schlott T, Jung T, Matthes C, Zwirner J, Riggert J, Peters JH. Ex vivo generation of human anti-melanoma autologous cytolytic T cells by dendritic cell/melanoma cell hybridomas. Cancer Immunol Immunother 2001; 50: 307-314. (PMID: 11570584)
11. Boon T, van der Bruggen P. Human tumor antigens recognized by T lymphocytes. J Exp Med 1996; 183: 725-729. (PMID: 8642276)
12. Stuhler G, Walden P. Recruitment of helper T cells for induction of tumour rejection by cytolytic T lymphocytes. Cancer Immunol Immunother 1994; 39: 342-345. (PMID: 7987867)
13. Gong J, Chen D, Kashiwaba M, Li Y, Chen L, Takeuchi H, Qu H, Rowse GJ, Gendler SJ, Kufe D. Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells. Proc Natl Acad Sci U S A 1998; 95: 6279-6283. (PMID: 9600956)
14. Wang J, Saffold S, Cao X, Krauss J, Chen W. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. J Immunol 1998; 161: 5516-5524. (PMID: 9820528)
15. Gong J, Apostolopoulos V, Chen D, Chen H, Koido S, Gendler SJ, McKenzie IF, Kufe D. Selection and characterization of MUC1-specific CD8+ T cells from MUC1 transgenic mice immunized with dendritic-carcinoma fusion cells. Immunology 2000; 101: 316-324. (PMID: 11106934)
16. Kugler A, Stuhler G, Walden P, Zoller G, Zobywalski A, Brossart P, Trefzer U, Ullrich S, Muller CA, Becker V, Gross AJ, Hemmerlein B, Kanz L, Muller GA, Ringert RH. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat Med 2000; 6: 332-336. (PMID: 10700237)
17. Scott-Taylor TH, Pettengell R, Clarke I, Stuhler G, La Barthe MC, Walden P, Dalgleish AG. Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines. Biochim Biophys Acta 2000; 1500: 265-279. (PMID: 10699368)
18. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, Knop J, Enk AH. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997; 27: 3135-3142. (PMID: 9464798)
19. Gong J, Nikrui N, Chen D, Koido S, Wu Z, Tanaka Y, Cannistra S, Avigan D, Kufe D. Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity. J Immunol 2000; 165: 1705-1711. (PMID: 10903782)
20. Elliott JA, Winn WC Jr. Treatment of alveolar macrophages with cytochalasin D inhibits uptake and subsequent growth of Legionella pneumophila. Infect Immun 1986; 51: 31-36. (PMID: 3941000)
21. Bellone M, Iezzi G, Rovere P, Galati G, Ronchetti A, Protti MP, Davoust J, Rugarli C, Manfredi AA. Processing of engulfed apoptotic bodies yields T cell epitopes. J Immunol 1997; 159: 5391-5399. (PMID: 9548479)
22. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392: 86-89. (PMID: 9510252)
23. Kohler G, Milstein C. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol 1976; 6: 511-519. (PMID: 825377)
24. Celluzzi CM, Falo LD Jr. Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection. J Immunol 1998; 160: 3081-3085. (PMID: 9531260)
25. Stuhler G, Walden P. Collaboration of helper and cytotoxic T lymphocytes. Eur J Immunol 1993; 23: 2279-2286. (PMID: 7690327)
26. Bennett SR, Carbone FR, Karamalis F, Miller JF, Heath WR. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med 1997; 186: 65-70. (PMID: 9206998)
27. Trefzer U, Weingart G, Chen Y, Herberth G, Adrian K, Winter H, Audring H, Guo Y, Sterry W, Walden P. Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanoma. Int J Cancer 2000; 85: 618-626. (PMID: 10699939)
28. Lahn M, Kunzmann R, Kohler G, Ikle DN, Hentrich I, Jesuiter H, Kulmburg P, Veelken H, Mackensen A, Rosenthal F, Lindemann A. Comparison of cytogenetics, cytokine secretion, and oncogene expression in primary cultures of renal carcinoma cells. Oncology 1997; 54: 429-437. (PMID: 9260606)
29. Jacob K, Bosserhoff AK, Wach F, Knuchel R, Klein EC, Hein R, Buettner R. Characterization of selected strongly and weakly invasive sublines of a primary human melanoma cell line and isolation of subtractive cDNA clones. Int J Cancer 1995; 60: 668-675. (PMID: 7532159)
30. Mackensen A, Veelken H, Lahn M, Wittnebel S, Becker D, Kohler G, Kulmburg P, Brennscheidt U, Rosenthal F, Franke B, Mertelsmann R, Lindemann A. Induction of tumor-specific cytotoxic T lymphocytes by immunization with autologous tumor cells and interleukin-2 gene transfected fibroblasts. J Mol Med 1997; 75: 290-296. (PMID: 9151215)
31. Krause SW, Kreutz M, Andreesen R. Isolation, characterisation and cultivation of human monocytes and macrophages. In: Kaufmann SHE, Kabelitz D, editors. Immunology of Infection. Academic Press; 1998. p. 663-684.
32. Meierhoff G, Krause SW, Andreesen R. Comparative analysis of dendritic cells derived from blood monocytes or CD34+ hematopoietic progenitor cells. Immunobiology 1998; 198: 501-513. (PMID: 9561369)